The glucose dependence of Akt-transformed cells can be reversed by pharmacologic activation of fatty acid β-oxidation

Monica Buzzai, Daniel E. Bauer, Russell G. Jones, Ralph J. DeBerardinis, Georgia Hatzivassiliou, Rebecca L. Elstrom, Craig B. Thompson

Research output: Contribution to journalArticle

258 Citations (Scopus)

Abstract

Activation of the oncogenic kinase Akt stimulates glucose uptake and metabolism in cancer cells and renders these cells susceptible to death in response to glucose withdrawal. Here we show that 5-aminoimidazole-4-carboxamide ribonucleoside (AICAR) reverses the sensitivity of Akt-expressing glioblastoma cells to glucose deprivation. AICAR's protection depends on the activation of AMPK, as expression of a dominant-negative form of AMPK abolished this effect. AMPK is a cellular energy sensor whose activation can both block anabolic pathways such as protein synthesis and activate catabolic reactions such as fatty acid oxidation to maintain cellular bioenergetics. While rapamycin treatment mimicked the effect of AICAR on inhibiting markers of cap-dependent translation, it failed to protect Akt-expressing cells from death upon glucose withdrawal. Compared to control cells, Akt-expressing cells were impaired in the ability to induce fatty acid oxidation in response to glucose deprivation unless stimulated with AICAR. Stimulation of fatty acid oxidation was sufficient to maintain cell survival as activation of fatty acid oxidation with bezafibrate also protected Akt-expressing cells from glucose withdrawal-induced death. Conversely, treatment with a CPT-1 inhibitor to block fatty acid import into mitochondria prevented AICAR from stimulating fatty acid oxidation and promoting cell survival in the absence of glucose. Finally, cell survival did not require reversal of Akt's effects on either protein translation or lipid synthesis as the addition of the cell penetrant oxidizable substrate methyl-pyruvate was sufficient to maintain survival of Akt-expressing cells deprived of glucose. Together, these data suggest that activation of Akt blocks the ability of cancer cells to metabolize nonglycolytic bioenergetic substrates, leading to glucose addiction.

Original languageEnglish (US)
Pages (from-to)4165-4173
Number of pages9
JournalOncogene
Volume24
Issue number26
DOIs
StatePublished - Jun 16 2005

Fingerprint

Fatty Acids
Glucose
AMP-Activated Protein Kinases
Cell Survival
Energy Metabolism
Bezafibrate
Protein Biosynthesis
Sirolimus
Glioblastoma
Neoplasms
Mitochondria
Cell Death
Phosphotransferases
Lipids
acadesine
Proteins

Keywords

  • Akt
  • AMPK
  • Fatty acid oxidation
  • Glucose
  • Metabolism

ASJC Scopus subject areas

  • Molecular Biology
  • Cancer Research
  • Genetics

Cite this

Buzzai, M., Bauer, D. E., Jones, R. G., DeBerardinis, R. J., Hatzivassiliou, G., Elstrom, R. L., & Thompson, C. B. (2005). The glucose dependence of Akt-transformed cells can be reversed by pharmacologic activation of fatty acid β-oxidation. Oncogene, 24(26), 4165-4173. https://doi.org/10.1038/sj.onc.1208622

The glucose dependence of Akt-transformed cells can be reversed by pharmacologic activation of fatty acid β-oxidation. / Buzzai, Monica; Bauer, Daniel E.; Jones, Russell G.; DeBerardinis, Ralph J.; Hatzivassiliou, Georgia; Elstrom, Rebecca L.; Thompson, Craig B.

In: Oncogene, Vol. 24, No. 26, 16.06.2005, p. 4165-4173.

Research output: Contribution to journalArticle

Buzzai, M, Bauer, DE, Jones, RG, DeBerardinis, RJ, Hatzivassiliou, G, Elstrom, RL & Thompson, CB 2005, 'The glucose dependence of Akt-transformed cells can be reversed by pharmacologic activation of fatty acid β-oxidation', Oncogene, vol. 24, no. 26, pp. 4165-4173. https://doi.org/10.1038/sj.onc.1208622
Buzzai, Monica ; Bauer, Daniel E. ; Jones, Russell G. ; DeBerardinis, Ralph J. ; Hatzivassiliou, Georgia ; Elstrom, Rebecca L. ; Thompson, Craig B. / The glucose dependence of Akt-transformed cells can be reversed by pharmacologic activation of fatty acid β-oxidation. In: Oncogene. 2005 ; Vol. 24, No. 26. pp. 4165-4173.
@article{9f17d998a90b49f8bf07e9dda09a5cba,
title = "The glucose dependence of Akt-transformed cells can be reversed by pharmacologic activation of fatty acid β-oxidation",
abstract = "Activation of the oncogenic kinase Akt stimulates glucose uptake and metabolism in cancer cells and renders these cells susceptible to death in response to glucose withdrawal. Here we show that 5-aminoimidazole-4-carboxamide ribonucleoside (AICAR) reverses the sensitivity of Akt-expressing glioblastoma cells to glucose deprivation. AICAR's protection depends on the activation of AMPK, as expression of a dominant-negative form of AMPK abolished this effect. AMPK is a cellular energy sensor whose activation can both block anabolic pathways such as protein synthesis and activate catabolic reactions such as fatty acid oxidation to maintain cellular bioenergetics. While rapamycin treatment mimicked the effect of AICAR on inhibiting markers of cap-dependent translation, it failed to protect Akt-expressing cells from death upon glucose withdrawal. Compared to control cells, Akt-expressing cells were impaired in the ability to induce fatty acid oxidation in response to glucose deprivation unless stimulated with AICAR. Stimulation of fatty acid oxidation was sufficient to maintain cell survival as activation of fatty acid oxidation with bezafibrate also protected Akt-expressing cells from glucose withdrawal-induced death. Conversely, treatment with a CPT-1 inhibitor to block fatty acid import into mitochondria prevented AICAR from stimulating fatty acid oxidation and promoting cell survival in the absence of glucose. Finally, cell survival did not require reversal of Akt's effects on either protein translation or lipid synthesis as the addition of the cell penetrant oxidizable substrate methyl-pyruvate was sufficient to maintain survival of Akt-expressing cells deprived of glucose. Together, these data suggest that activation of Akt blocks the ability of cancer cells to metabolize nonglycolytic bioenergetic substrates, leading to glucose addiction.",
keywords = "Akt, AMPK, Fatty acid oxidation, Glucose, Metabolism",
author = "Monica Buzzai and Bauer, {Daniel E.} and Jones, {Russell G.} and DeBerardinis, {Ralph J.} and Georgia Hatzivassiliou and Elstrom, {Rebecca L.} and Thompson, {Craig B.}",
year = "2005",
month = "6",
day = "16",
doi = "10.1038/sj.onc.1208622",
language = "English (US)",
volume = "24",
pages = "4165--4173",
journal = "Oncogene",
issn = "0950-9232",
publisher = "Nature Publishing Group",
number = "26",

}

TY - JOUR

T1 - The glucose dependence of Akt-transformed cells can be reversed by pharmacologic activation of fatty acid β-oxidation

AU - Buzzai, Monica

AU - Bauer, Daniel E.

AU - Jones, Russell G.

AU - DeBerardinis, Ralph J.

AU - Hatzivassiliou, Georgia

AU - Elstrom, Rebecca L.

AU - Thompson, Craig B.

PY - 2005/6/16

Y1 - 2005/6/16

N2 - Activation of the oncogenic kinase Akt stimulates glucose uptake and metabolism in cancer cells and renders these cells susceptible to death in response to glucose withdrawal. Here we show that 5-aminoimidazole-4-carboxamide ribonucleoside (AICAR) reverses the sensitivity of Akt-expressing glioblastoma cells to glucose deprivation. AICAR's protection depends on the activation of AMPK, as expression of a dominant-negative form of AMPK abolished this effect. AMPK is a cellular energy sensor whose activation can both block anabolic pathways such as protein synthesis and activate catabolic reactions such as fatty acid oxidation to maintain cellular bioenergetics. While rapamycin treatment mimicked the effect of AICAR on inhibiting markers of cap-dependent translation, it failed to protect Akt-expressing cells from death upon glucose withdrawal. Compared to control cells, Akt-expressing cells were impaired in the ability to induce fatty acid oxidation in response to glucose deprivation unless stimulated with AICAR. Stimulation of fatty acid oxidation was sufficient to maintain cell survival as activation of fatty acid oxidation with bezafibrate also protected Akt-expressing cells from glucose withdrawal-induced death. Conversely, treatment with a CPT-1 inhibitor to block fatty acid import into mitochondria prevented AICAR from stimulating fatty acid oxidation and promoting cell survival in the absence of glucose. Finally, cell survival did not require reversal of Akt's effects on either protein translation or lipid synthesis as the addition of the cell penetrant oxidizable substrate methyl-pyruvate was sufficient to maintain survival of Akt-expressing cells deprived of glucose. Together, these data suggest that activation of Akt blocks the ability of cancer cells to metabolize nonglycolytic bioenergetic substrates, leading to glucose addiction.

AB - Activation of the oncogenic kinase Akt stimulates glucose uptake and metabolism in cancer cells and renders these cells susceptible to death in response to glucose withdrawal. Here we show that 5-aminoimidazole-4-carboxamide ribonucleoside (AICAR) reverses the sensitivity of Akt-expressing glioblastoma cells to glucose deprivation. AICAR's protection depends on the activation of AMPK, as expression of a dominant-negative form of AMPK abolished this effect. AMPK is a cellular energy sensor whose activation can both block anabolic pathways such as protein synthesis and activate catabolic reactions such as fatty acid oxidation to maintain cellular bioenergetics. While rapamycin treatment mimicked the effect of AICAR on inhibiting markers of cap-dependent translation, it failed to protect Akt-expressing cells from death upon glucose withdrawal. Compared to control cells, Akt-expressing cells were impaired in the ability to induce fatty acid oxidation in response to glucose deprivation unless stimulated with AICAR. Stimulation of fatty acid oxidation was sufficient to maintain cell survival as activation of fatty acid oxidation with bezafibrate also protected Akt-expressing cells from glucose withdrawal-induced death. Conversely, treatment with a CPT-1 inhibitor to block fatty acid import into mitochondria prevented AICAR from stimulating fatty acid oxidation and promoting cell survival in the absence of glucose. Finally, cell survival did not require reversal of Akt's effects on either protein translation or lipid synthesis as the addition of the cell penetrant oxidizable substrate methyl-pyruvate was sufficient to maintain survival of Akt-expressing cells deprived of glucose. Together, these data suggest that activation of Akt blocks the ability of cancer cells to metabolize nonglycolytic bioenergetic substrates, leading to glucose addiction.

KW - Akt

KW - AMPK

KW - Fatty acid oxidation

KW - Glucose

KW - Metabolism

UR - http://www.scopus.com/inward/record.url?scp=20544449673&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=20544449673&partnerID=8YFLogxK

U2 - 10.1038/sj.onc.1208622

DO - 10.1038/sj.onc.1208622

M3 - Article

C2 - 15806154

AN - SCOPUS:20544449673

VL - 24

SP - 4165

EP - 4173

JO - Oncogene

JF - Oncogene

SN - 0950-9232

IS - 26

ER -